Skoetz N - Search Results

1

Mindfulness-based interventions for substance use disorders.

Goldberg SB, Pace B, Griskaitis M, Willutzki R, Skoetz N, Thoenes S, Zgierska AE, Rösner S. Goldberg SB, et al. Among authors: skoetz n. Cochrane Database Syst Rev. 2021 Oct 20;10(10):CD011723. doi: 10.1002/14651858.CD011723.pub2. Cochrane Database Syst Rev. 2021. PMID: 34668188 Free PMC article. Review.

2

Conceptualizing the reporting of living systematic reviews.

Khabsa J, Chang S, McKenzie JE, Barker JM, Boutron I, Kahale LA, Page MJ, Skoetz N, Akl EA. Khabsa J, et al. Among authors: skoetz n. J Clin Epidemiol. 2023 Apr;156:113-118. doi: 10.1016/j.jclinepi.2023.01.008. Epub 2023 Feb 1. J Clin Epidemiol. 2023. PMID: 36736707 Review.

3

Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma.

Herbst C, Rehan FA, Skoetz N, Bohlius J, Brillant C, Schulz H, Monsef I, Specht L, Engert A. Herbst C, et al. Among authors: skoetz n. Cochrane Database Syst Rev. 2011 Feb 16;(2):CD007110. doi: 10.1002/14651858.CD007110.pub2. Cochrane Database Syst Rev. 2011. PMID: 21328291 Free article. Updated. Review.

4

Therapeutic interventions for Burkitt lymphoma in children.

Okebe JU, Skoetz N, Meremikwu MM, Richards S. Okebe JU, et al. Among authors: skoetz n. Cochrane Database Syst Rev. 2011 Jul 6;2011(7):CD005198. doi: 10.1002/14651858.CD005198.pub3. Cochrane Database Syst Rev. 2011. PMID: 21735399 Free PMC article. Review.

5

Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma.

Bauer K, Skoetz N, Monsef I, Engert A, Brillant C. Bauer K, et al. Among authors: skoetz n. Cochrane Database Syst Rev. 2011 Aug 10;(8):CD007941. doi: 10.1002/14651858.CD007941.pub2. Cochrane Database Syst Rev. 2011. PMID: 21833963 Updated. Review.

6

High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.

Schaaf M, Reiser M, Borchmann P, Engert A, Skoetz N. Schaaf M, et al. Among authors: skoetz n. Cochrane Database Syst Rev. 2012 Jan 18;1:CD007678. doi: 10.1002/14651858.CD007678.pub2. Cochrane Database Syst Rev. 2012. PMID: 22258971 Review.

7

Alemtuzumab for patients with chronic lymphocytic leukaemia.

Skoetz N, Bauer K, Elter T, Monsef I, Roloff V, Hallek M, Engert A. Skoetz N, et al. Cochrane Database Syst Rev. 2012 Feb 15;2012(2):CD008078. doi: 10.1002/14651858.CD008078.pub2. Cochrane Database Syst Rev. 2012. PMID: 22336834 Free PMC article. Review.

8

Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia.

Bauer K, Rancea M, Roloff V, Elter T, Hallek M, Engert A, Skoetz N. Bauer K, et al. Among authors: skoetz n. Cochrane Database Syst Rev. 2012 Nov 14;11(11):CD008079. doi: 10.1002/14651858.CD008079.pub2. Cochrane Database Syst Rev. 2012. PMID: 23152253 Free PMC article. Review.

9

Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL).

Bergner N, Monsef I, Illerhaus G, Engert A, Skoetz N. Bergner N, et al. Among authors: skoetz n. Cochrane Database Syst Rev. 2012 Nov 14;11:CD009355. doi: 10.1002/14651858.CD009355.pub2. Cochrane Database Syst Rev. 2012. PMID: 23152274 Review.

10

High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma.

Rancea M, Monsef I, von Tresckow B, Engert A, Skoetz N. Rancea M, et al. Among authors: skoetz n. Cochrane Database Syst Rev. 2013 Jun 20;(6):CD009411. doi: 10.1002/14651858.CD009411.pub2. Cochrane Database Syst Rev. 2013. PMID: 23784872 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

177 results

Search Page